Periodontitis is a chronic inflammatory disease that is largely attributable to infections with gram-negative bacteria and is characterized by both gingival inflammation and alveolar bone resorption. Localized aggressive periodontitis (LagP) is an early-onset form of disease that develops during the circumpubertal period, and the periodontal destruction is most apparent around the first molars and incisors (34) . Actinobacillus actinomycetemcomitans is strongly associated with LagP, and this association is supported by the presence of high titers in serum of immunoglobulin G2 (IgG2) that is reactive with surface carbohydrates of A. actinomycetemcomitans (40) . LagP patients have features consistent with a Th1 bias, including Th1 cytokines in the gingival crevicular fluid (GCF) (33) and high levels of gamma interferon (IFN-␥)-dependent IgG2 in their sera and GCF (22, 39, 40) . Remarkably, the high levels of IgG2 that is reactive with the serotype-specific carbohydrates of A. actinomycetemcomitans and Porphyromonas gingivalis correlate with a significant reduction in the extent and severity of the disease, suggesting that the IgG2 response is protective (5, 14) .
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) and are the only APCs that are capable of priming naïve T cells (16, 24, 37) . Furthermore, the priming events include the polarization of naïve T cells toward a Th1 or Th2 response (3, 20, 31) . DCs, including Langerhans cells and dermal DCs, are found in large numbers in the gingival tissue, and mature CD83
ϩ DCs have been found in gingival tissues from patients with periodontitis (7, 18, 19) . Furthermore, dermal DCs, which have similarities with monocyte-derived DCs (mDCs), have been identified in gingival tissue in association with T cells in periodontitis, suggesting a DC-mediated T-cell activation (18) . Recent findings also indicated that the pathogen-DC interface plays a major role in skewing responses toward Th1 or Th2 and that this is determined in large measure by the Toll-like receptors (TLRs) on DCs engaged by the pathogen (30) . TLR4 agonists are known to promote the production of the interleukin-12 (IL-12)-and IFN-␥-inducible protein 10 . In contrast, TLR2 stimulation typically failed to induce these cytokines but may release the IL-12 inhibitory p40 homodimer and conditions that are predicted to favor Th2 development (30) . In addition, DCs are potent stimulators of NK cells, and NKT cells are the most abundant IFN-␥-producing cells in the mouse after a lipopolysaccharide (LPS) challenge (11, 13, 26, 28, 43) .
Recently, members of our laboratory found that DCs spontaneously emerge in cultures of LagP monocytes and that mDCs selectively promote IgG2 production (2). These results prompted the hypothesis that the initial host-pathogen interface established between A. actinomycetemcomitans and immature DCs might enhance IFN-␥ production, which in turn might promote immunopathology as well as protective IgG2 expression (1, 4, 9, 17, 22, 35, 38, 39) . To begin testing, we compared the levels of IL-12 production by mDCs and macrophages stimulated with Escherichia coli and A. actinomycetemcomitans. We also compared the abilities of DCs stimulated with these organisms to induce the production of IFN-␥ by peripheral blood lymphocytes (PBL) from seronegative subjects. We found that A. actinomycetemcomitans-or A. actinomycetemcomitans LPS-stimulated mDCs induced high levels of IL-12 and that these DCs induced NK cells of the normal PBL to produce IFN-␥ in large quantities within just 24 h, in the absence of detectable IL-4. The ability of A. actinomycetemcomitans-stimulated DCs to induce this rapid NK cell response may help to explain the Th1-associated cytokines in LagP GCF and the high levels of IFN-␥-dependent IgG2.
MATERIALS AND METHODS
Human subjects. Subjects for this study were obtained by the Clinical Research Center for Periodontal Disease, School of Dentistry, Virginia Commonwealth University, Richmond, Va. PBL were isolated from heparinized whole blood from seronegative nonperiodontitis (NP) patients who had no evidence of attachment loss except for recession on the buccal surfaces of anterior teeth at no more than one site and with no pockets of Ͼ3 mm.
Reagents. Recombinant human IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, a monoclonal anti-human IL-12 antibody, and a mouse IgG1 isotype control were obtained from R&D Systems (Minneapolis, Minn.). A monoclonal anti-human TLR4 antibody and a mouse IgG2a isotype control were obtained from eBioscience (San Diego, Calif.). LPS from E. coli (serotype O26:B6) was obtained from Sigma Chemical Co. (St. Louis, Mo.). LPS from A. actinomycetemcomitans Y4 was prepared as previously described (42) .
Bacteria. A. actinomycetemcomitans strain Y4, E. coli strain DH5␣, and P. gingivalis strain W83 were employed in this study. In preliminary studies, we found that E. coli (DH5␣) was a more potent and reliable inducer of DC IL-12 than a smooth strain of E. coli (O26:B6), which was the source of the commercial LPS used in our study. Because E. coli DH5␣ was a better stimulator of DC IL-12, it was used for most experiments. A. actinomycetemcomitans and P. gingivalis were grown in brain heart infusion medium (Difco Laboratories, Detroit, Mich.), and E. coli was grown in Luria-Bertani broth (Fisher Scientific, Fairlawn, N.J.). After being cultured, the bacteria were washed three times with phosphate-buffered saline and resuspended to an appropriate concentration in the same buffer. All bacteria, including the controls, were heated at 65°C for 30 min before they were used in cultures. Treatment at this temperature is known to inactivate the A. actinomycetemcomitans leukotoxin.
To study trapping by DCs, we grew the bacteria in 5 ml of medium pulsed with 50 Ci of [ 3 H]oleic acid. After an overnight incubation, E. coli strain DH5␣ had incorporated 34,400 cpm/10 7 bacteria, E. coli strain O26:B6 had incorporated 30,400 cpm/10 7 bacteria, and A. actinomycetemcomitans strain Y4 had incorporated 126,000 cpm/10 7 bacteria. Lymphocyte separation. PBL were obtained from heparinized blood by density centrifugation using lymphocyte separation medium (ICN, Aurora, Ohio). The cells were centrifuged at 400 ϫ g for 20 min, collected from the interface, and washed three times in RPMI 1640 medium (Cellgro, Herndon, Va.). After being washed, the cells were suspended in RPMI 1640 supplemented with 10% fetal calf serum (HyClone, Logan, Utah) and antibiotics for cell culture. mDC and macrophage cultures. Adherent monocytes were prepared by culturing PBL (2 ϫ 10 7 cells/well) in six-well culture plates (35-mm diameter; Costar) for 1 h. The adherent cells were washed and then cultured for 5 days in medium enriched with 10% fetal calf serum, 500 U of recombinant human IL-4/ml, and 800 U of recombinant human GM-CSF/ml for the generation of mDCs or 1,000 U of recombinant human M-CSF/ml for the generation of macrophages (32) . In each experiment, monocytes were obtained from a single donor and then some were converted into mDCs and others were converted into macrophages. Different donors were used to reproduce the experiments, but statistics were done within experiments with DCs, macrophages, NK cells, and T cells from the same donor.
Magnetic cell separation. A magnetic cell separation system (MACS; Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany) was used to separate NK cells and/or CD8 cells from other mononuclear cells. PBL were incubated with antibodies against CD56 and/or CD8 that had been conjugated directly to the Miltenyi microbeads. After being washed, the cell pellet was resuspended and loaded onto LS separation columns that were seated in a strong magnetic field. The labeled cells were trapped in the columns and the cells in the effluent were used as CD56-depleted and/or CD8-depleted cells. The columns were then removed from the separator, and the CD56-or CD8-labeled cells were flushed out and used. The efficiency of depletion was determined by using fluorescein isothiocyanate-or phycoerythrin-conjugated antibodies against CD56 or CD8 (BD Biosciences, San Diego, Calif.) and then was evaluated by flow cytometry (FACScan; Becton Dickinson, Mansfield, Mass.). The depletion of CD56-positive cells was in excess of 95%, and the depletion of CD8-positive cells was over 80%.
Cocultures of mDCs or macrophages with PBL. A total of 10 6 PBL were resuspended in 1 ml of RPMI 1640 supplemented with 10% fetal calf serum and cultured in 75-mm 2 tubes (Falcon, Lincoln Park, N.J.) at 37°C in a humidified atmosphere containing 5% CO 2 . Cultures also contained the indicated numbers of mDCs or macrophages from the same subject with an anti-human IL-12 or anti-human TLR4 antibody. The supernatant fluids were collected at the indicated times and the concentration of IFN-␥ was measured.
ELISA. IFN-␥, IL-4, IL-12 p70, and IL-10 levels in the culture supernatants were evaluated by using enzyme-linked immunosorbent assay (ELISA) kits purchased from R&D Systems according to the manufacturer's instructions. The detection limits for the various assays were as follows: 15.6 pg/ml for IFN-␥, 31.5 pg/ml for IL-4 and IL-12 p70, and 62.5 pg/ml for IL-10.
Flow cytometry. Cell surface CD56, CD8, and CD86 were analyzed by flow cytometry. Cells (10 6 ) were incubated with 5 l of a fluorescein isothiocyanatelabeled anti-CD56, phycoerythrin-conjugated anti-CD8, or Cy-chrome-conjugated anti-CD86 antibody (BD Biosciences) for 30 min on ice in the dark. The cells were washed once and resuspended in phosphate-buffered saline (Gibco, Grand Island, N.Y.) containing 2% fetal bovine serum. The mean fluorescence intensity was then determined by use of a flow cytometer (FACScan; Becton Dickinson). Approximately 10,000 cells were included in each analysis.
Statistical analysis. All experiments were repeated a minimum of three times and the cultures were done in triplicate. Group means were compared by analysis of variance followed by Tukey's honestly significant difference. Significance was accepted at P values of Ͻ0.05.
RESULTS
A. actinomycetemcomitans induced DCs but not macrophages to produce IL-12 p70. DCs are typically the first APCs to encounter invading microbes, and the engagement of innate pattern recognition receptors (e.g., TLR4 for LPS) leads to DC maturation and antigen presentation. We reasoned that A. actinomycetemcomitans would stimulate immature DCs and that the interaction might promote IFN-␥ production. To begin testing this hypothesis, we stimulated immature mDCs from NP subjects with heat-killed A. actinomycetemcomitans, E. coli, or P. gingivalis for comparison. The addition of A. actinomycetemcomitans to immature mDCs dramatically increased the induction of IL-12, and A. actinomycetemcomitans was the most potent stimulator (Fig. 1A) . The results in Fig. 1B are for mDCs from human umbilical cord blood, which we reasoned should represent a population with minimal prior exposure to cytokines from activated lymphocytes. The results confirm the remarkable ability of A. actinomycetemcomitans to stimulate IL-12 production by DCs. In marked contrast to the case for mDCs, the addition of A. actinomycetemcomitans to macrophages did not result in increased IL-12 production (Fig.  1A) . Induction of the Th2-polarizing cytokine IL-10 by the same bacteria in mDC and macrophage cultures was also studied, and both cell types produced similar levels (Fig. 2) . However, a tendency for macrophages to produce slightly more IL-10 was apparent in all three experiments in this series.
The remarkable ability of A. actinomycetemcomitans to stimulate IL-12 production prompted experiments to determine whether DCs engage A. actinomycetemcomitans more efficiently than E. coli. The bacteria were labeled with [ 3 H]oleic acid, and then labeled bacteria (10 6 /culture) were incubated with DCs at 10 6 /DC in 1 ml of medium. After 1 h, the DCs were washed vigorously and the percentage of bacteria trapped by DCs was determined. Fourteen percent of the most stimu-latory E. coli strain DH5␣ cells, which were used in the experiments for Fig. 1 and 2 , had been trapped by DCs in the first hour of incubation and 9% of strain O26:B6 cells had been trapped, but only 2.5% of A. actinomycetemcomitans cells had been trapped. In short, it appears that DCs engage E. coli more efficiently than A. actinomycetemcomitans and that the lower activity of E. coli for stimulating DC IL-12 is not due to a problem in trapping E. coli.
A. actinomycetemcomitans-stimulated mDCs induced early IFN-␥ production by PBL. The ability of A. actinomycetemcomitans or A. actinomycetemcomitans LPS to stimulate IL-12 production by mDCs prompted the hypothesis that the addition of mDCs to normal PBL should enhance the IFN-␥ response. When mDCs were added to NP PBL and stimulated with A. actinomycetemcomitans, a DC-dependent increase in IFN-␥ production was apparent by 24 h (Fig. 3A) . In contrast with the case for DCs, the addition of macrophages to PBL stimulated with A. actinomycetemcomitans failed to induce levels of IFN-␥ that were significantly above the background, although there was some scatter in the data at days 2 and 3 ( Fig. 3B) . In most experiments, the simple addition of A. actinomycetemcomitans was sufficient to elicit detectable levels of IFN-␥ production; this phenomenon was previously described by Kobayashi et al. (23) . This IFN-␥ response may be attributable to the presence of some DCs in the PBL, but the addition of more DCs clearly enhanced IFN-␥ production. We were unable to detect IL-4 (our detection limit was 31.5 pg/ml) in the first 72 h in DCs or macrophages stimulated with A. actinomycetemcomitans or E. coli.
NK cells as an important source of early IFN-␥.
Given the ability of A. actinomycetemcomitans-stimulated DCs to induce IFN-␥ production within 24 h and the known ability of NK cells to rapidly respond (43), we sought to determine if this rapid IFN-␥ response might be attributable to NK cells (CD56 ϩ cells). We compared IFN-␥ production in PBL, PBL depleted of NK cells, and positively selected CD56 ϩ cells treated with A. actinomycetemcomitans, with or without mDCs (Fig. 4A) . The depletion of CD56 ϩ cells from PBL significantly reduced the DC-dependent production of IFN-␥. Furthermore, A. actinomycetemcomitans-stimulated mDCs induced a potent IFN-␥ response by the CD56 ϩ cells. In contrast, the addition of macrophages failed to increase the production of IFN-␥ and even suppressed the background level obtained by adding A. actinomycetemcomitans to CD56 ϩ cells (data not shown). The importance of NK cells was further supported by experiments demonstrating that allogeneic mDCs stimulated with A. actinomycetemcomitans could elicit a potent IFN-␥ response after 24 h, indicating a lack of major histocompatibility complex restriction (data not shown). Although the removal of CD56 ϩ cells from PBL did eliminate most IFN-␥ production, 25 to 45% remained, indicating that another type of cell also contributed to the early IFN-␥ response. Recent reports indicated that DC CD8
ϩ -T-cell interaction can result in rapid IFN-␥ responses (21) , prompting us to examine the effect of removing CD8 ϩ T cells, and as indicated in Fig. 4B , the activity after the NK cells had been removed could be largely attributed to CD8 ϩ cells. Thus, NK cells appear to be the major contributor to the early IFN-␥ response in PBL induced by mDCs stimulated by A. actinomycetemcomitans, but CD8 ϩ cells also contribute to the response.
DC-derived IL-12 and optimal induction of early IFN-␥ response. IL-12 is known to stimulate NK cells. To investigate the role of IL-12, we treated PBL (with or without mDCs) with an anti-IL-12 neutralizing antibody followed by stimulation with A. actinomycetemcomitans. As shown in Fig. 5 , treatment with an anti-IL-12 antibody markedly inhibited the early production of IFN-␥.
TLR4 involvement in early Th1 cytokine response. TLR4 agonists such as LPS are known to promote the production of IL-12 by DCs (15), and we reasoned that A. actinomycetemcomitans LPS should promote IL-12 production and that an anti-TLR4 antibody should inhibit the IL-12 response. These predictions were substantiated when mDCs were treated with or without an anti-TLR4 neutralizing antibody followed by stimulation with A. actinomycetemcomitans LPS (Fig. 6A) . To confirm that the IFN-␥ response induced by intact A. actinomycetemcomitans in PBL was dependent on TLR4, we treated PBL with 10 5 mDCs, with or without the anti-TLR4 antibody, followed by stimulation with A. actinomycetemcomitans. As predicted, the A. actinomycetemcomitans-induced early IFN-␥ response was inhibited by the anti-TLR4 antibody (Fig. 6B) .
Comparisons of the A. actinomycetemcomitans and E. coli LPSs indicated that A. actinomycetemcomitans LPS was a better inducer of DC IL-12 (data not shown), and these results were consistent with the IL-12 data obtained by using whole bacteria (Fig. 1) . Similarly, when the A. actinomycetemcomitans and E. coli LPSs were compared for the ability to upregulate the DC costimulatory molecule CD86, A. actinomycetemcomitans LPS was a better stimulator ( Table 1 ). Note that about 1 ng of E. coli LPS was required to significantly upregulate CD86 expression on immature DCs and that a comparable response was obtained with only 0.1 ng of A. actinomycetemcomitans LPS.
DISCUSSION
The data reported here indicate that A. actinomycetemcomitans-stimulated mDCs secrete IL-12 and promote a rapid IFN-␥ response by NK cells. DCs can produce IL-12 in its bioactive form, which is a 70-kDa heterodimer consisting of IL-12 p40 and p35 that must be expressed in the same cell to generate the heterodimer. The assay used here was specific for the 70-kDa heterodimer, which favors the differentiation of precursor Th0 cells into Th1 effectors (12, 27, 36, 41) . Furthermore, A. actinomycetemcomitans was a more powerful inducer of IL-12 than E. coli or P. gingivalis (Fig. 1A) . Similarly, A. actinomycetemcomitans LPS induced more DC IL-12 than did E. coli LPS, and A. actinomycetemcomitans LPS had more ability to upregulate the costimulatory molecule CD86 on DCs (Table 1 ). This could be relevant, given that IL-12 and CD86 have been implicated in the ability of bacteria to promote the production of IFN-␥ by murine NKT cells and NK cells (43) . P. gingivalis LPS is not a good TLR4 stimulator and is capable of interfering with activation by other TLR4 agonists (45) , but E. coli stimulates cells well and is frequently used to mature DCs for Th1 responses (29) . Thus, the data presented here suggest that A. actinomycetemcomitans might be a better stimulator than E. coli for maturing DCs for Th1 responses designed for use in cancer therapy or for intracellular infections. Our results indicating that bacterium-stimulated mDCs produced IL-12 p70 are also consistent with a critical role for DCs in the rapid production of IFN-␥. Both mDCs and macrophages responded to A. actinomycetemcomitans by producing similar levels of the Th2-polarizing cytokine IL-10 ( Fig. 2) . According to previous reports, IL-10 inhibits human lymphocyte IFN-␥ production by suppressing NK cell stimulatory factor or IL-12 synthesis in accessory cells (10) . Thus, mDCs seem to control the type of inflammatory response by secreting two functionally conflicting factors, and the ratio of IL-12 to IL-10 is thought to determine the balance of a Th1 versus Th2 response. The absolute amount of IL-10 was larger than that of IL-12 for both E. coli and A. actinomycetemcomitans, but IL-4 was not found in ei- ther case and IL-12 production was preferentially induced by A. actinomycetemcomitans. In short, the cytokine response induced by A. actinomycetemcomitans-stimulated mDCs suggests that there is skewing toward a Th1 response, and these cytokines may help to explain the high levels of IFN-␥-dependent IgG2 that is reactive with A. actinomycetemcomitans in sera and GCF of LagP patients. A recent report indicated that A. actinomycetemcomitans often stimulates the production of IFN-␥ when it is incubated with PBL from seronegative subjects (23) . Since A. actinomycetemcomitans stimulates mDCs to secrete IL-12 ( Fig. 1) , we reasoned that the addition of mDCs to normal PBL should enhance the IFN-␥ response. We confirmed that A. actinomycetemcomitans could stimulate IFN-␥ production when incubated with normal PBL (Fig. 4B ) and found that IFN-␥ responses dramatically increased when mDCs were added with the A. actinomycetemcomitans. The observations that high levels of IFN-␥ were apparent in just 24 h and that the IFN-␥ was largely produced by NK cells (Fig. 3A) extend our understanding of A. actinomycetemcomitans-induced IFN-␥ production by normal PBL.
The interaction of DCs with A. actinomycetemcomitans, leading to IL-12 production followed by the rapid production of IFN-␥ by NK cells, is an important response at the innate level. These cytokines are capable of promoting Th1 development and thus influencing the development of the adaptive immune response. The observation that IFN-␥ production was at a high level within just 24 h prompted studies to determine if NK cells were the predominant IFN-␥ producers after stimulation with A. actinomycetemcomitans. The depletion of NK cells from PBL decreased the amount of IFN-␥ about twothirds (Fig. 4) , and the balance was largely attributable to CD8 ϩ cells. It has previously been reported that CD8 ϩ cells may serve as an early source of IFN-␥ (21) , and that appears to be the case here.
Certain microbial antigens are known to stimulate IL-12 production, and IL-12 is critical to the optimal induction of IFN-␥ production by NK cells and T cells (12, 41) . Our studies with a neutralizing anti-IL-12 antibody confirmed that IL-12 is a Monocytes were cultured with GM-CSF and IL-4 for 5 days, and then various concentrations of LPS from E. coli or A. actinomycetemcomitans were added for 1 day.
b The background fluorescence intensity for CD86 on DCs in the absence of any LPS was 102 Ϯ 6.4. Data are means Ϯ SE. critical for A. actinomycetemcomitans-stimulated DCs to induce early IFN-␥ production (Fig. 5) . This rapid IFN-␥ response also suggests that A. actinomycetemcomitans stimulation favors the differentiation of precursor Th0 cells into Th1 effectors.
LPSs from gram-negative bacteria appear to be important in the pathogenesis of periodontal disease (8) . Our data for the neutralizing anti-TLR4 antibody, which has been identified as a signaling receptor of the innate system that is capable of recognizing LPS (45) , showed that TLR4 is important in the pathway leading to IL-12 production by mDCs upon A. actinomycetemcomitans LPS stimulation (Fig. 6A) . Furthermore, the optimal early IFN-␥ response induced in PBL by A. actinomycetemcomitans-stimulated mDCs was also TLR4 dependent (Fig. 6B) . These results are consistent with the concepts that LPS is a significant component in the induction of early IFN-␥ production by A. actinomycetemcomitans and that LPS-TLR4 interactions on DCs initiate the pathway leading to the production of IFN-␥ by NK cells and CD8 ϩ cells. The data reported here indicate that A. actinomycetemcomitans-stimulated mDCs have the ability to promote a rapid IFN-␥ response in healthy subjects by stimulating IFN-␥ production by cells of the innate immune system. This DC-dependent pathway may help to provide the IFN-␥ necessary for the high levels of IgG2 that are associated with less severe periodontal disease (5, 6, 25, 44) . However, it is also of some concern that the prolonged production of Th1 cytokines in sites of chronic inflammation has been associated with tissue damage (1, 4, 9, 17, 35, 38) . Thus, the DC-driven immune response to A. actinomycetemcomitans could help to induce adaptive immune responses that might have destructive as well as protective effects.
